Nizatidine Market
Nizatidine Market Analysis By Type (Nizatidine Capsules, Nizatidine Tablets), By Distribution Channel (Nizatidine for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), & By Region - Global Insights to 2031
Analysis of Nizatidine market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Market Outlook for Nizatidine
Newly published data by Fact.MR estimates the global market for nizatidine to flourish at an impressive 9% value CAGR across the 2021-2031 assessment period. Expected valuation for the market by the end of the said decade is likely to reach US$ 12.2 Bn, while as of 2021, the expected market value is US$ 5.1 Bn.
Key Points Covered in Nizatidine Industry Survey
- Market estimates and forecast 2016-2031
- Key drivers and restraints impacting market growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand share and Market Share Analysis
- Key Product Innovations and Regulatory Conditions
- COVID-19 Impact on Nizatidine Market and How to Navigate
- Recommendation on Key Winning Strategies
Consumption Analysis of Nizatidine 2016-2020 vs Outlook 2021-2031
According to Fact.MR- a market research and competitive intelligence provider- the market for nizatidine experienced a noteworthy upsurge from 2016 to 2020, expanding at a CAGR of 7%. Growth is riding on the back of rising prevalence of gastric disorders.
Attributed to its anti-inflammatory effects, nizatidine is being investigated in order to develop anti-viral drugs which could prove to be highly effective in countering the COVID-19 pandemic. Various pharmaceutical giants are ramping up efforts to fast track the development of nizatidine infused drugs.
In addition, numerous well-known companies have won approval to sell their products in new areas, boosting their growth chances. Over the forthcoming decade, the market is expected to grow at a rate of 9% in value CAGR terms.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Rising Healthcare Costs to Drive Nizatidine-based Treatment Market?
Globally, as healthcare infrastructure improves, overall spending on high-quality treatment is increasing. This is largely due to the combination of modern technologies and innovative therapeutic approaches. This is true even for the treatment of gastrointestinal problems.
Various pharmaceutical grade treatments, such as nizatidine medicines, have been developed as effective alternatives. These medications are readily available online or over-the-counter at low prices, making them accessible to people of all socioeconomic backgrounds.
How is Nizatidine Uptake Fueled by Increasing Awareness of Gastric Disorders?
According to the British Medical Association (BMA), non-communicable diseases (NCDs) account for 60% of the worldwide illness burden, with stomach disorders accounting for the majority of this total. As a result, regional-level measures are ongoing to address this issue.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is financing research studies in the United States to better understand the complex connections between genetic, environmental, immunological, and microbial variables that contribute to stomach disorders. Such endeavors are also assisting in the development of nizatidine-based medications.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Voluntary Product Recalls to Disrupt Nizatidine Market Expansion?
In 2020, the U.S Food and Drug Administration announced a voluntary recall of ranitidine and nizatidine tablets by two major manufacturers, Appco Pharma and Mylan N.V., in early 2020. While the former recalled all of its tablets, the latter pulled three batches of nizatidine capsules from the market.
The aforementioned recalls were prompted by a significant risk of contamination due to NDMA levels exceeding the FDA's permitted daily intake guidelines, which is a probable carcinogen. As a result, product releases are likely to be postponed, limiting growth opportunities.
Country-wise Analysis
Why will India Witness High Growth over the Upcoming Years?
According to the India Brand Equity Foundation , India is the world's largest provider of generic medications, and the home market is predicted to grow threefold by 2031, with medicine spending expected to increase by more than 9%. (IBEF). As a result, nizatidine sales are expected to grow in the next years.
Currently, nizatidine is produced in India by a small number of well-known pharmaceutical businesses. Glenmark Pharmaceuticals, Dr. Reddy's Laboratories, and Strides Pharma Science are the companies in question. More players are expected to emerge in the Indian environment as regulatory approvals are expedited. The Indian market is poised to surge at a CAGR of 8.5% by 2031, according to Fact.MR
What are the Prospects for Nizatidine Sales in the U.S?
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) estimates that 60 to 70 million people are affected by digestive diseases, with over 20 million hospitalizations. Diverticulosis, GI infections, and gastroesophageal reflux were among the most common.
As a result, the use of antihistamines to reduce excessive gastric juice production is on the rise, boosting nizatidine sales. Certain companies, such as Amneal Pharmaceuticals Inc., have been given permission to resume sales of their nizatidine oral solutions, indicating that future growth is possible. As per Fact.MR, the U.S market is poised to surge at a CAGR of 7.2% until 2031.
Why is China Expected to be an Attractive Market for Nizatidine?
It is apprehended that China accounts for a significant chunk of irritable bowel syndrome- affecting between 4 to 7% of the population. According to the National Center for Biotechnology Information (NCBI), China is one of the countries with the heaviest burden of gastric cancer (GC).
The number of incident cases of GC increased from 317.34 thousand in 1990 to 612.82 thousand in 2019, while the age-standardized incidence rate (ASIR) of GC decreased from 37.56 per 100,000 in 1990 to 30.64 per 100,000 in 2019, hence providing immense opportunities for enhanced nizatidine sales. Owing to these factors, sales of nizatidine drugs are likely to accelerate at an impressive 8% CAGR.
Category-wise Insights
Is Nizatidine Product Sales Increasing Through Retail and Online Channels?
While hospital pharmacies remain the principal source of nizatidine capsules and tablets, sales at retail and online pharmacies are fast expanding at a CAGR of about 14%, owing to the convenience of access and availability.
The fast growth of over-the-counter pharmacies and online medical stores is providing leading nizatidine manufacturers with a better platform to sell their medicines to potential customers.
Nizatidine Capsules to witness huge demand over the upcoming years?
Nizatidine capsule sales are expected to outperform other forms, such as tablets and powder, with a CAGR of over 10% from 2021 to 2031. These capsules are offered in two doses to treat duodenal ulcers: 150 mg and 300 mg, respectively.
Nizatidine capsules operate faster than tablets because they break down faster, and they are less likely to have a disagreeable taste or odor, which is especially useful for those who have trouble swallowing tablets.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Competitive Landscape
Prominent nizatidine manufacturers are reliant on regulatory sanctions from appropriate authorities to market their products, besides resorting to strategies such as mergers, acquisitions and collaborations.
- Glenmark Pharmaceuticals, a major Indian manufacturer, offers a range of Nizatidine Oral Capsules composed of a dosage of 300 milligrams, specifically manufactured for treating active duodenal ulcers.
- Likewise, Dr. Reddy’s Laboratories offers nizatidine for inhibiting gastrointestinal- GI H2 receptor antagonists which are synthetically manufactured and available in oral solid and liquid formats.
- MedChemExpress, another prominent player, manufactures nizatidine for uptake across stomach and intestine ulcers. It works by secreting the secretion of gastric acid the stomach produces, thereby preventing ulcer recurrence.
Report Scope
|
Attribute |
Details |
|
Market size value in 2020 |
USD 5.1 Billion |
|
Market forecast value in 2031 |
USD 12.2 Billion |
|
Growth Rate |
CAGR of 9% from 2021 to 2031 |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
US$ Mn for Value & ‘000 Units for Volume |
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Key Segments Covered
-
Type
- Nizatidine Capsules
- Nizatidine Tablets
- Other Nizatidine Types
-
Distribution Channel
- Nizatidine for Hospital Pharmacies
- Nizatidine for Retail Pharmacies
- Nizatidine for Online Pharmacies
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product modifications /Innovation 4. Key Success Factors 4.1. Strategic Developments 4.2. Key regulations 4.3. Product USPs /Technology 4.4. List of manufacturers and providers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP outlook 5.1.2. Increasing R&D Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. New product launches 5.2.2. Cost of products 5.2.3. Increasing adoption of Nizatidines 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1.1. Current COVID19 Statistics and Probable Future Impact 6.1.2. Current GDP Projection and Probable Impact 6.1.3. Current Economic Projection as compared to 2008 Economic analysis 6.1.4. COVID19 and Impact Analysis 6.1.4.1. Revenue By Type 6.1.4.2. Revenue By Application 6.1.4.3. Revenue By Country 6.1.5. 2020 Market Scenario 6.1.6. Quarter by Quarter Forecast 6.1.7. Projected Recovery Quarter 7. Global Nizatidine Market Volume (Units) Analysis 2016-2020 and Forecast, 2021-2031 7.1. Historical Market Volume (Units) Analysis, 2016-2020 7.2. Current and Future Market Volume (Units) Projections, 2021-2031 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Nizatidine Market - Pricing Analysis 8.1. Regional Pricing Analysis By Type 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global Nizatidine Market Value Analysis 2016–2020 and Forecast, 2021-2031 9.1. Historical Market Value (US$ Mn) Analysis, 2016–2020 9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Nizatidine Market Analysis 2016–2020 and Forecast 2021-2031, by Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Products & Services, 2016–2020 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2021-2031 10.3.1. Capsules 10.3.2. Tablets 10.3.3. Others 10.4. Market Attractiveness Analysis By Type 11. Global Nizatidine Market Analysis 2016–2020 and Forecast 2021-2031, by Application 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Application , 2016–2020 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application , 2021-2031 11.3.1. Hospital Pharmacies 11.3.2. Retail Pharmacies 11.3.3. Online Pharmacies 11.4. Market Attractiveness Analysis By Application 12. Global Nizatidine Market Analysis 2016–2020 and Forecast 2021-2031, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2016–2020 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Nizatidine Market Analysis 2016–2020 and Forecast 2021-2031 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Type 13.3.3. By Application 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Nizatidine Market Analysis 2016–2020 and Forecast 2021-2031 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Type 14.3.3. By Application 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Nizatidine Market Analysis 2016–2020 and Forecast 2021-2031 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. Rest of Europe 15.3.2. By Type 15.3.3. By Application 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Nizatidine Market Analysis 2016–2020 and Forecast 2021-2031 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Type 16.3.3. By Application 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Nizatidine Market Analysis 2016–2020 and Forecast 2021-2031 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.1.4. Rest of East Asia 17.3.2. By Type 17.3.3. By Application 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Nizatidine Market Analysis 2016–2020 and Forecast 2021-2031 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Type 18.3.3. By Application 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Nizatidine Market Analysis 2016–2020 and Forecast 2021-2031 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. South Africa 19.3.1.3. Rest of Middle East and Africa 19.3.2. By Type 19.3.3. By Application 19.4. Market Attractiveness Analysis 19.5. Drivers and Restraints - Impact Analysis 20. Key and Emerging Countries Nizatidine Market Analysis 2016–2020 and Forecast 2021-2031 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Nizatidine Market Analysis 20.2.1. By Type 20.2.2. By Application 20.3. Canada Nizatidine Market Analysis 20.3.1. By Type 20.3.2. By Application 20.4. Mexico Nizatidine Market Analysis 20.4.1. By Type 20.4.2. By Application 20.5. Brazil Nizatidine Market Analysis 20.5.1. By Type 20.5.2. By Application 20.6. U.K. Nizatidine Market Analysis 20.6.1. By Type 20.6.2. By Application 20.7. Germany Nizatidine Market Analysis 20.7.1. By Type 20.7.2. By Application 20.8. France Nizatidine Market Analysis 20.8.1. By Type 20.8.2. By Application 20.9. Italy Nizatidine Market Analysis 20.9.1. By Type 20.9.2. By Application 20.10. Spain Nizatidine Market Analysis 20.10.1. By Type 20.10.2. By Application 20.11. BENELUX Nizatidine Market Analysis 20.11.1. By Type 20.11.2. By Application 20.12. Russia Nizatidine Market Analysis 20.12.1. By Type 20.12.2. By Application 20.13. China Nizatidine Market Analysis 20.13.1. By Type 20.13.2. By Application 20.14. Japan Nizatidine Market Analysis 20.14.1. By Type 20.14.2. By Application 20.15. South Korea Nizatidine Market Analysis 20.15.1. By Type 20.15.2. By Application 20.16. India Nizatidine Market Analysis 20.16.1. By Type 20.16.2. By Application 20.17. ASEAN Nizatidine Market Analysis 20.17.1. By Type 20.17.2. By Application 20.18. Australia Nizatidine Market Analysis 20.18.1. By Type 20.18.2. By Application 20.19. New Zealand Nizatidine Market Analysis 20.19.1. By Type 20.19.2. By Application 20.20. GCC Countries Nizatidine Market Analysis 20.20.1. By Type 20.20.2. By Application 20.21. Turkey Nizatidine Market Analysis 20.21.1. By Type 20.21.2. By Application 20.22. South Africa Nizatidine Market Analysis 20.22.1. By Type 20.22.2. By Application 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 21.4.1. By Regional footprint of Players 21.4.2. Product foot print by Players 21.4.3. Channel Foot Print by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep dive 22.3.1. Flynn Pharma 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Profitability by Market Segments (Product/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.1.5.1. Marketing Strategy 22.3.1.5.2. Product Strategy 22.3.1.5.3. Channel Strategy 22.3.2. MedChemExpress 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Profitability by Market Segments (Product/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.2.5.1. Marketing Strategy 22.3.2.5.2. Product Strategy 22.3.2.5.3. Channel Strategy 22.3.3. Mylan N.V. 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Profitability by Market Segments (Product/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.3.5.1. Marketing Strategy 22.3.3.5.2. Product Strategy 22.3.3.5.3. Channel Strategy 22.3.4. Glenmark Pharmaceuticals 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Profitability by Market Segments (Product/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.4.5.1. Marketing Strategy 22.3.4.5.2. Product Strategy 22.3.4.5.3. Channel Strategy 22.3.5. Weightech (Hunan) Pharmaceutical 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Profitability by Market Segments (Product/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.5.5.1. Marketing Strategy 22.3.5.5.2. Product Strategy 22.3.5.5.3. Channel Strategy 22.3.6. Hengdian Group 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Profitability by Market Segments (Product/Channel/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.6.5.1. Marketing Strategy 22.3.6.5.2. Product Strategy 22.3.6.5.3. Channel Strategy 22.3.7. Dr. Reddy’s Laboratories 22.3.7.1. Overview 22.3.7.2. Product Portfolio 22.3.7.3. Profitability by Market Segments (Product/Channel/Region) 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.7.5.1. Marketing Strategy 22.3.7.5.2. Product Strategy 22.3.7.5.3. Channel Strategy 22.3.8. Eli Lily and Company 22.3.8.1. Overview 22.3.8.2. Product Portfolio 22.3.8.3. Profitability by Market Segments (Product/Channel/Region) 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 22.3.8.5.1. Marketing Strategy 22.3.8.5.2. Product Strategy 22.3.8.5.3. Channel Strategy 22.3.9. Strides Pharma Science Limited 22.3.9.1. Overview 22.3.9.2. Product Portfolio 22.3.9.3. Profitability by Market Segments (Product/Channel/Region) 22.3.9.4. Sales Footprint 22.3.9.5. Strategy Overview 22.3.9.5.1. Marketing Strategy 22.3.9.5.2. Product Strategy 22.3.9.5.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Nizatidine Market Volume (‘000 Units) Analysis and Opportunity Assessment 2016–2031, By Type
Table 02: Global Nizatidine Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Type
Table 03: Global Nizatidine Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application
Table 04: Global Nizatidine Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Region
Table 05: North America Nizatidine Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 06: North America Nizatidine Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Type
Table 07: North America Nizatidine Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application
Table 08: Latin America Nizatidine Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 09: Latin America Nizatidine Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Type
Table 10: Latin America Nizatidine Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application
Table 11: Europe Nizatidine Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 12: Europe Nizatidine Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Type
Table 13: Europe Nizatidine Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application
Table 14: South Asia Nizatidine Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 15: South Asia Nizatidine Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Type
Table 16: South Asia Nizatidine Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application
Table 17: East Asia Nizatidine Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 18: East Asia Nizatidine Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Type
Table 19: East Asia Nizatidine Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application
Table 20: Oceania Nizatidine Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 21: Oceania Nizatidine Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Type
Table 22: Oceania Nizatidine Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application
Table 23: Middle East and Africa Nizatidine Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 24: Middle East and Africa Nizatidine Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Type
Table 25: Middle East and Africa Nizatidine Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Nizatidine Market Volume (in 000' Units) Analysis, 2016-2020
Figure 02: Global Nizatidine Market Volume Forecast (in 000' Units), 2021-2031
Figure 03: Nizatidine Pricing Analysis (US$) Per Product, By Region, 2020
Figure 04: Nizatidine Pricing Analysis (US$) Per Product, By Region, 2020
Figure 05: Global Nizatidine Market Value Analysis (US$ Mn), 2016-2020
Figure 06: Global Nizatidine Market Value Forecast (US$ Mn), 2021-2031
Figure 07: Global Nizatidine Market Absolute $ Opportunity, 2021-2031
Figure 08: Global Nizatidine Market Share Analysis (%), By Type, 2021-2031
Figure 09: Global Nizatidine Market Y-o-Y Analysis (%), By Type, 2021-2031
Figure 10: Global Nizatidine Market Attractiveness Analysis by Type, 2021-2031
Figure 11: Global Nizatidine Market Share Analysis (%), By Application, 2021-2031
Figure 12: Global Nizatidine Market Y-o-Y Analysis (%), By Application, 2021-2031
Figure 13: Global Nizatidine Market Attractiveness Analysis by Application, 2021-2031
Figure 14: Global Nizatidine Market Share Analysis (%), By Region, 2021-2031
Figure 15: Global Nizatidine Market Y-o-Y Analysis (%), By Region, 2021-2031
Figure 16: Global Nizatidine Market Attractiveness Analysis by Region, 2021-2031
Figure 17: North America Nizatidine Market Value Share, By Type, 2021 (E)
Figure 18: North America Nizatidine Market Value Share, By Application, 2021 (E)
Figure 19: North America Nizatidine Market Value Share, By Country, 2021 (E)
Figure 20: North America Nizatidine Market Value Analysis (US$ Mn), 2016-2020
Figure 21: North America Nizatidine Market Value Forecast (US$ Mn), 2021-2031
Figure 22: North America Nizatidine Market Attractiveness Analysis by Type, 2021-2031
Figure 23: North America Nizatidine Market Attractiveness Analysis by Application, 2021-2031
Figure 24: North America Nizatidine Market Attractiveness Analysis by Country, 2021-2031
Figure 25: Latin America Nizatidine Market Value Share, By Type, 2021 (E)
Figure 26: Latin America Nizatidine Market Value Share, By Application, 2021 (E)
Figure 27: Latin America Nizatidine Market Value Share, By Country, 2021 (E)
Figure 28: Latin America Nizatidine Market Value Analysis (US$ Mn), 2016-2020
Figure 29: Latin America Nizatidine Market Value Forecast (US$ Mn), 2021-2031
Figure 30: Latin America Nizatidine Market Attractiveness Analysis by Type, 2021-2031
Figure 31: Latin America Nizatidine Market Attractiveness Analysis by Application, 2021-2031
Figure 32: Latin America Nizatidine Market Attractiveness Analysis by Country, 2021-2031
Figure 33: Europe Nizatidine Market Value Share, By Type, 2021 (E)
Figure 34: Europe Nizatidine Market Value Share, By Application, 2021 (E)
Figure 35: Europe Nizatidine Market Value Share, By Country, 2021 (E)
Figure 36: Europe Nizatidine Market Value Analysis (US$ Mn), 2016-2020
Figure 37: Europe Nizatidine Market Value Forecast (US$ Mn), 2021-2031
Figure 38: Europe Nizatidine Market Attractiveness Analysis by Type, 2021-2031
Figure 39: Europe Nizatidine Market Attractiveness Analysis by Application, 2021-2031
Figure 40: Europe Nizatidine Market Attractiveness Analysis by Country, 2021-2031
Figure 41: South Asia Nizatidine Market Value Share, By Type, 2021 (E)
Figure 42: South Asia Nizatidine Market Value Share, By Application, 2021 (E)
Figure 43: South Asia Nizatidine Market Value Share, By Country, 2021 (E)
Figure 44: South Asia Nizatidine Market Value Analysis (US$ Mn), 2016-2020
Figure 45: South Asia Nizatidine Market Value Forecast (US$ Mn), 2021-2031
Figure 46: South Asia Nizatidine Market Attractiveness Analysis by Type, 2021-2031
Figure 47: South Asia Nizatidine Market Attractiveness Analysis by Application, 2021-2031
Figure 48: South Asia Nizatidine Market Attractiveness Analysis by Country, 2021-2031
Figure 49: East Asia Nizatidine Market Value Share, By Type, 2021 (E)
Figure 50: East Asia Nizatidine Market Value Share, By Application, 2021 (E)
Figure 51: East Asia Nizatidine Market Value Share, By Country, 2021 (E)
Figure 52: East Asia Nizatidine Market Value Analysis (US$ Mn), 2016-2020
Figure 53: East Asia Nizatidine Market Value Forecast (US$ Mn), 2021-2031
Figure 54: East Asia Nizatidine Market Attractiveness Analysis by Type, 2021-2031
Figure 55: East Asia Nizatidine Market Attractiveness Analysis by Application, 2021-2031
Figure 56: East Asia Nizatidine Market Attractiveness Analysis by Country, 2021-2031
Figure 57: Oceania Nizatidine Market Value Share, By Type, 2021 (E)
Figure 58: Oceania Nizatidine Market Value Share, By Application, 2021 (E)
Figure 59: Oceania Nizatidine Market Value Share, By Country, 2021 (E)
Figure 60: Oceania Nizatidine Market Value Analysis (US$ Mn), 2016-2020
Figure 61: Oceania Nizatidine Market Value Forecast (US$ Mn), 2021-2031
Figure 62: Oceania Nizatidine Market Attractiveness Analysis by Type, 2021-2031
Figure 63: Oceania Nizatidine Market Attractiveness Analysis by Application, 2021-2031
Figure 64: Oceania Nizatidine Market Attractiveness Analysis by Country, 2021-2031
Figure 65: Middle East and Africa Nizatidine Market Value Share, By Type, 2021 (E)
Figure 66: Middle East and Africa Nizatidine Market Value Share, By Application, 2021 (E)
Figure 67: Middle East and Africa Nizatidine Market Value Share, By Country, 2021 (E)
Figure 68: Middle East and Africa Nizatidine Market Value Analysis (US$ Mn), 2016-2020
Figure 69: Middle East and Africa Nizatidine Market Value Forecast (US$ Mn), 2021-2031
Figure 70: Middle East and Africa Nizatidine Market Attractiveness Analysis by Type, 2021-2031
Figure 71: Middle East and Africa Nizatidine Market Attractiveness Analysis by Application, 2021-2031
Figure 72: Middle East and Africa Nizatidine Market Attractiveness Analysis by Country, 2021-2031
Figure 73: U. S. Nizatidine Market Value Analysis (US$ Mn), 2021 & 2031
Figure 74: U. S. Nizatidine Market Value Share, By Type, 2021 (E)
Figure 75: U. S. Nizatidine Market Value Share, By Application, 2021 (E)
Figure 76: Canada Nizatidine Market Value Analysis (US$ Mn), 2021 & 2031
Figure 77: Canada Nizatidine Market Value Share, By Type, 2021 (E)
Figure 78: Canada Nizatidine Market Value Share, By Application, 2021 (E)
Figure 79: Mexico Nizatidine Market Value Analysis (US$ Mn), 2021 & 2031
Figure 80: Mexico Nizatidine Market Value Share, By Type, 2021 (E)
Figure 81: Mexico Nizatidine Market Value Share, By Application, 2021 (E)
Figure 82: Brazil Nizatidine Market Value Analysis (US$ Mn), 2021 & 2031
Figure 83: Brazil Nizatidine Market Value Share, By Type, 2021 (E)
Figure 84: Brazil Nizatidine Market Value Share, By Application, 2021 (E)
Figure 85: U. K. Nizatidine Market Value Analysis (US$ Mn), 2021 & 2031
Figure 86: U. K. Nizatidine Market Value Share, By Type, 2021 (E)
Figure 87: U. K. Nizatidine Market Value Share, By Application, 2021 (E)
Figure 88: Germany Nizatidine Market Value Analysis (US$ Mn), 2021 & 2031
Figure 89: Germany Nizatidine Market Value Share, By Type, 2021 (E)
Figure 90: Germany Nizatidine Market Value Share, By Application, 2021 (E)
Figure 91: France Nizatidine Market Value Analysis (US$ Mn), 2021 & 2031
Figure 92: France Nizatidine Market Value Share, By Type, 2021 (E)
Figure 93: France Nizatidine Market Value Share, By Application, 2021 (E)
Figure 94: Italy Nizatidine Market Value Analysis (US$ Mn), 2021 & 2031
Figure 95: Italy Nizatidine Market Value Share, By Type, 2021 (E)
Figure 96: Italy Nizatidine Market Value Share, By Application, 2021 (E)
Figure 97: Spain Nizatidine Market Value Analysis (US$ Mn), 2021 & 2031
Figure 98: Spain Nizatidine Market Value Share, By Type, 2021 (E)
Figure 99: Spain Nizatidine Market Value Share, By Application, 2021 (E)
Figure 100: Russia Nizatidine Market Value Analysis (US$ Mn), 2021 & 2031
Figure 101: Russia Nizatidine Market Value Share, By Type, 2021 (E)
Figure 102: Russia Nizatidine Market Value Share, By Application, 2021 (E)
Figure 103: China Nizatidine Market Value Analysis (US$ Mn), 2021 & 2031
Figure 104: China Nizatidine Market Value Share, By Type, 2021 (E)
Figure 105: China Nizatidine Market Value Share, By Application, 2021 (E)
Figure 106: Japan Nizatidine Market Value Analysis (US$ Mn), 2021 & 2031
Figure 107: Japan Nizatidine Market Value Share, By Type, 2021 (E)
Figure 108: Japan Nizatidine Market Value Share, By Application, 2021 (E)
Figure 109: South Korea Nizatidine Market Value Analysis (US$ Mn), 2021 & 2031
Figure 110: South Korea Nizatidine Market Value Share, By Type, 2021 (E)
Figure 111: South Korea Nizatidine Market Value Share, By Application, 2021 (E)
Figure 112: India Nizatidine Market Value Analysis (US$ Mn), 2021 & 2031
Figure 113: India Nizatidine Market Value Share, By Type, 2021 (E)
Figure 114: India Nizatidine Market Value Share, By Application, 2021 (E)
Figure 115: ASEAN Nizatidine Market Value Analysis (US$ Mn), 2021 & 2031
Figure 116: ASEAN Nizatidine Market Value Share, By Type, 2021 (E)
Figure 117: ASEAN Nizatidine Market Value Share, By Application, 2021 (E)
Figure 118: Australia Nizatidine Market Value Analysis (US$ Mn), 2021 & 2031
Figure 119: Australia Nizatidine Market Value Share, By Type, 2021 (E)
Figure 120: Australia Nizatidine Market Value Share, By Application, 2021 (E)
Figure 121: New Zealand Nizatidine Market Value Analysis (US$ Mn), 2021 & 2031
Figure 122: New Zealand Nizatidine Market Value Share, By Type, 2021 (E)
Figure 123: New Zealand Nizatidine Market Value Share, By Application, 2021 (E)
Figure 124: GCC Countries Nizatidine Market Value Analysis (US$ Mn), 2021 & 2031
Figure 125: GCC Countries Nizatidine Market Value Share, By Type, 2021 (E)
Figure 126: GCC Countries Nizatidine Market Value Share, By Application, 2021 (E)
Figure 127: Turkey Nizatidine Market Value Analysis (US$ Mn), 2021 & 2031
Figure 128: Turkey Nizatidine Market Value Share, By Type, 2021 (E)
Figure 129: Turkey Nizatidine Market Value Share, By Application, 2021 (E)
Figure 130: South Africa Nizatidine Market Value Analysis (US$ Mn), 2021 & 2031
Figure 131: South Africa Nizatidine Market Value Share, By Type, 2021 (E)
Figure 132: South Africa Nizatidine Market Value Share, By Application, 2021 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the nizatidine industry worth?
According to Fact.MR, nizatidine sales are expected to reach US$ 5.1 Bn as of 2021
What was the last 5 years market CAGR for nizatidine?
From 2016 to 2020, nizatidine sales expanded at a CAGR of 7% according to Fact.MR
What is the anticipated outlook for the nizatidine market until 2031?
From 2021 to 2031, nizatidine sales are expected to register a CAGR of 9% in value terms
What is the expected market value for nizatidine as of 2031?
As of 2031, nizatidine sales are expected to be valued at US$ 12.2 Bn according to Fact.MR
What is driving demand for nizatidine medicines?
The ever increasing burden of gastric disorders and other chronic ailments will likely spur sales of nizatidine drugs
What are the expansion prospects in the U.S?
Nizatidine sales in the U.S are expected to register a CAGR of 7.2% from 2021 to 2031
How lucrative are growth prospects across India?
The Indian market for nizatidine is poised to expand 3x from 2021 to 2031, as per Fact.MR
What growth prospects abound across the market in China?
According to Fact.MR, China is expected to register a CAGR of 8% from 2021 to 2031
Which type of nizatidine drugs are expected to remain in the limelight?
Nizatidine capsules are expected to experience a staggering 10% CAGR until 2031
Which are some prominent manufacturers of nizatidine?
Flynn Pharma, MedChemExpress and Glenmark Pharmaceuticals are some prominent nizatidine manufacturers profiled by Fact.MR.
Nizatidine Market